Duprez L, Parma J, Van Sande J, Allgeier A, Leclère J, Schvartz C, Delisle M J, Decoulx M, Orgiazzi J, Dumont J
Institut de Recherche Interdisciplinaire, Faculty of Medicine, University of Brussels, Belgium.
Nat Genet. 1994 Jul;7(3):396-401. doi: 10.1038/ng0794-396.
The thyrotropin receptor (TSHR), a member of the large family of G protein-coupled receptors, controls both the function and growth of thyroid cells via stimulation of adenylyl cyclase. We report two different mutations in the TSHR gene of affected members of two large pedigrees with non-autoimmune autosomal dominant hyperthyroidism (toxic thyroid hyperplasia), that involve residues in the third (Val509Ala) and seventh (Cys672Tyr) transmembrane segments. When expressed by transfection in COS-7 cells, the mutated receptors display a higher constitutive activation of adenylyl cyclase than wild type. This new disease entity is the germline counterpart of hyperfunctioning thyroid adenomas, in which different somatic mutations with similar functional characteristics have been demonstrated.
促甲状腺激素受体(TSHR)是G蛋白偶联受体大家族的一员,通过刺激腺苷酸环化酶来控制甲状腺细胞的功能和生长。我们报告了两个患有非自身免疫性常染色体显性甲状腺功能亢进症(毒性甲状腺增生)的大家族中受影响成员的TSHR基因的两种不同突变,这些突变涉及第三(Val509Ala)和第七(Cys672Tyr)跨膜段中的残基。当通过转染在COS-7细胞中表达时,突变受体显示出比野生型更高的腺苷酸环化酶组成性激活。这种新的疾病实体是高功能甲状腺腺瘤的种系对应物,在高功能甲状腺腺瘤中已证实存在具有相似功能特征的不同体细胞突变。